Rituximab for immune hemolytic anemia following T- and b-cell-depleted hematopoietic stem cell transplantation

P. Corti; S. Bonanomi; C. Vallinoto; A. Balduzzi; C. Uderzo; G. Cazzaniga; G. Gaipa; M. Dassi; P. Perseghin; Attilio Rovelli

doi:10.1159/000067271

Rituximab for immune hemolytic anemia following T- and b-cell-depleted hematopoietic stem cell transplantation

P. Corti
, S. Bonanomi
, C. Vallinoto
, A. Balduzzi
, C. Uderzo
, G. Cazzaniga
, G. Gaipa
, M. Dassi
, P. Perseghin
, Attilio Rovelli

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Abstract

The treatment of immune-mediated hemolytic anemia (IHA) complicating hem atopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred after T-and B-cell depleted unrelated donor HSCT carried out for mucopolysaccharidosis type I-H (Hurler syndrome) which was successfully treated with anti-CD20+ monoclonal antibody.

Original language	English
Pages (from-to)	43-45
Number of pages	3
Journal	Acta Haematologica
Volume	109
Issue number	1
DOIs	https://doi.org/10.1159/000067271
State	Published - 2003
Externally published	Yes

Keywords

Hematopoietic stem cell transplantation
Hurler syndrome
Immune hemolytic anemia
Storage diseases

Access to Document

10.1159/000067271

Cite this

@article{ec0a4eb3d8e2446e8675244324f035fb,

title = "Rituximab for immune hemolytic anemia following T- and b-cell-depleted hematopoietic stem cell transplantation",

abstract = "The treatment of immune-mediated hemolytic anemia (IHA) complicating hem atopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred after T-and B-cell depleted unrelated donor HSCT carried out for mucopolysaccharidosis type I-H (Hurler syndrome) which was successfully treated with anti-CD20+ monoclonal antibody.",

keywords = "Hematopoietic stem cell transplantation, Hurler syndrome, Immune hemolytic anemia, Storage diseases",

author = "P. Corti and S. Bonanomi and C. Vallinoto and A. Balduzzi and C. Uderzo and G. Cazzaniga and G. Gaipa and M. Dassi and P. Perseghin and Attilio Rovelli",

year = "2003",

doi = "10.1159/000067271",

language = "English",

volume = "109",

pages = "43--45",

journal = "Acta Haematologica",

issn = "0001-5792",

publisher = "S. Karger AG",

number = "1",

}

TY - JOUR

T1 - Rituximab for immune hemolytic anemia following T- and b-cell-depleted hematopoietic stem cell transplantation

AU - Corti, P.

AU - Bonanomi, S.

AU - Vallinoto, C.

AU - Balduzzi, A.

AU - Uderzo, C.

AU - Cazzaniga, G.

AU - Gaipa, G.

AU - Dassi, M.

AU - Perseghin, P.

AU - Rovelli, Attilio

PY - 2003

Y1 - 2003

N2 - The treatment of immune-mediated hemolytic anemia (IHA) complicating hem atopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred after T-and B-cell depleted unrelated donor HSCT carried out for mucopolysaccharidosis type I-H (Hurler syndrome) which was successfully treated with anti-CD20+ monoclonal antibody.

AB - The treatment of immune-mediated hemolytic anemia (IHA) complicating hem atopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred after T-and B-cell depleted unrelated donor HSCT carried out for mucopolysaccharidosis type I-H (Hurler syndrome) which was successfully treated with anti-CD20+ monoclonal antibody.

KW - Hematopoietic stem cell transplantation

KW - Hurler syndrome

KW - Immune hemolytic anemia

KW - Storage diseases

UR - https://www.scopus.com/pages/publications/19044400950

U2 - 10.1159/000067271

DO - 10.1159/000067271

M3 - Article

C2 - 12486323

AN - SCOPUS:19044400950

SN - 0001-5792

VL - 109

SP - 43

EP - 45

JO - Acta Haematologica

JF - Acta Haematologica

IS - 1

ER -

Rituximab for immune hemolytic anemia following T- and b-cell-depleted hematopoietic stem cell transplantation

Abstract

Keywords

Access to Document

Fingerprint

Cite this